BIORESTORATIVE THERAPIES AUGUST 21, 2018 PROXY STATEMENT

Company

BioRestorative Therapies, Inc.

Filed

July 10, 2018

Period of Report

August 21, 2018

Accession Number

0001021771-18-000044

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →